Zepbound, a new version of the popular diabetes treatment Mounjaro, can now be sold as a weight-loss drug and helped patients lose 25% of their weight.
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The FDA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher, or those who are overweight with a related health condition, like high blood pressure, high cholesterol or diabetes. The drug should be paired with a healthy diet and regular exercise, the FDA said.The drug tirzepatide in Zepbound and Mounjaro and semaglutide in Wegovy and Ozempic work by mimicking hormones that kick in after people eat to regulate appetite and the feeling of fullness.
Touted by celebrities and on social media, semaglutide and tirzepatide drugs have already been in such demand that their manufacturers have struggled to keep up. Both have been listed on the FDA’s drug shortage site for months. All strengths of tirzepatide are currently listed as available, but a company spokesperson said that could vary by location and demand.
“Most patients won’t be able to afford Zepbound without insurance coverage and many health plans exclude obesity care,” said Dr. Katherine Saunders, an obesity expert at New York’s Weill Cornell Medicine and co-founder of company focused on obesity treatment.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Zepbound: FDA approves new version of diabetes drug Mounjaro for weight lossThe U.S. Food and Drug Administration on Wednesday approved a new version of the type 2 diabetes drug tirzepatide for use in chronic weight management, officials said.
Read more »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug.
Read more »
FDA approves new version of diabetes drug Mounjaro for weight lossA new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
Read more »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug.
Read more »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug.
Read more »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug
Read more »